

These medicinal products require prescription either by primary care physicians or by specialists or form an integral part of hospital treatment. Prescription Medicines, which represents the bulk of our Human Pharmaceuticals business, accounts for 79 % of our total net sales and generated in 2009 10,058 million euro.
Boehringer Ingelheim's product portfolio covers the following main indications:
Just to mention a few of our other indications: